While type 1 MIs continue to dominate, the prevalence of type 2 MIs has grown in recent years among Medicare beneficiaries, an observational study shows. The shift has implications for care, ...
Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results